As of June 30, 2025, Oncoinvent ASA has 609,941.00 shares outstanding.
| Shares Outstanding | 609,941.00 |
As of June 30, 2025, Oncoinvent ASA maintains a current ratio of 4.39, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.39 |
| Quick Ratio | 3.34 |
These figures cover the twelve months ended June 30, 2025.
| Employee Count | 25.00 |
As of June 30, 2025, Oncoinvent ASA holds 65.92M in cash and equivalents against - - in total debt, resulting in a net debt position of -65.92M. Total book value stands at 67.00M, with working capital of 66.93M providing operational flexibility.
| Cash & Cash Equivalents | 65.92M |
| Net Debt | -65.92M |
| Equity (Book Value) | 67.00M |
| Book Value Per Share | 109.85 |
| Working Capital | 66.93M |
Oncoinvent ASA's most recent stock split took place on January 19, 2026 with a 100:1 split ratio.
| Last Split Date | 1/19/2026 |
| Split Ratio | 100:1 |
Already premium?